{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:32:30Z","timestamp":1782333150689,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.canlet.2013.08.031","type":"journal-article","created":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T20:16:49Z","timestamp":1377375409000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: Suppressing effects of EGCG on the development of liver lesions"],"prefix":"10.1016","volume":"342","author":[{"given":"Takahiro","family":"Kochi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Terakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Shirakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tsurumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisataka","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2013.08.031_b0005","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1002\/cncr.24687","article-title":"Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link","volume":"115","author":"Siegel","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2013.08.031_b0010","doi-asserted-by":"crossref","first-page":"G697","DOI":"10.1152\/ajpgi.00426.2010","article-title":"Obesity, diabetes mellitus, and liver fibrosis","volume":"300","author":"Chiang","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.canlet.2013.08.031_b0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gtc.2004.12.012","article-title":"Hepatic complications of obesity","volume":"34","author":"Diehl","year":"2005","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.canlet.2013.08.031_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.freeradbiomed.2011.10.003","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis","volume":"52","author":"Rolo","year":"2012","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.canlet.2013.08.031_b0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000336913","article-title":"Molecular hepatic carcinogenesis: impact of inflammation","volume":"30","author":"Szabo","year":"2012","journal-title":"Dig. Dis."},{"key":"10.1016\/j.canlet.2013.08.031_b0030","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.08.031_b0035","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jhep.2009.01.018","article-title":"Deletion of angiotensin II type I receptor reduces hepatic steatosis","volume":"50","author":"Nabeshima","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2013.08.031_b0040","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1089\/ars.2005.7.1346","article-title":"Liver fibrogenesis: a new role for the renin-angiotensin system","volume":"7","author":"Bataller","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.canlet.2013.08.031_b0045","article-title":"The role of angiotensin II in nonalcoholic steatohepatitis","author":"Matthew Morris","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.canlet.2013.08.031_b0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.physbeh.2010.03.018","article-title":"The renin angiotensin system and the metabolic syndrome","volume":"100","author":"de Kloet","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.canlet.2013.08.031_b0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","article-title":"Japan NASH Study Group, Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma","volume":"9","author":"Yasui","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2013.08.031_b0060","doi-asserted-by":"crossref","first-page":"G147","DOI":"10.1152\/ajpgi.00462.2007","article-title":"Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver","volume":"296","author":"Moreno","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.canlet.2013.08.031_b0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2353\/ajpath.2009.080697","article-title":"Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats","volume":"174","author":"Wei","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2013.08.031_b0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1440-1681.2004.03962.x","article-title":"Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa\/fa) rats","volume":"31","author":"Hiraoka-Yamamoto","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.canlet.2013.08.031_b0075","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1291\/hypres.31.1021","article-title":"Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)\/IzmDmcr rats as a new model of metabolic syndrome","volume":"31","author":"Ueno","year":"2008","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.canlet.2013.08.031_b0080","doi-asserted-by":"crossref","first-page":"14700","DOI":"10.3390\/ijms140714700","article-title":"Enhanced development of azoxymethane-induced colonic preneoplastic lesions in hypertensive rats","volume":"14","author":"Kochi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2013.08.031_b0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2010.12.013","article-title":"Weight control and prevention of metabolic syndrome by green tea","volume":"64","author":"Sae-tan","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2013.08.031_b0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3945\/jn.109.115972","article-title":"Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity","volume":"140","author":"Grove","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.canlet.2013.08.031_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phytochem.2008.11.011","article-title":"The potential role of green tea catechins in the prevention of the metabolic syndrome \u2013 a review","volume":"70","author":"Thielecke","year":"2009","journal-title":"Phytochemistry"},{"key":"10.1016\/j.canlet.2013.08.031_b0100","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/mnfr.201000622","article-title":"Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases","volume":"55","author":"Shimizu","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.canlet.2013.08.031_b0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1940-6207.CAPR-08-0045","article-title":"(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL\/KsJ-db\/db mice","volume":"1","author":"Shimizu","year":"2008","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.canlet.2013.08.031_b0110","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1349-7006.2009.01241.x","article-title":"(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis","volume":"100","author":"Shirakami","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2013.08.031_b0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1158\/1940-6207.CAPR-10-0331","article-title":"Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL\/KsJ-db\/db mice","volume":"4","author":"Shimizu","year":"2011","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.canlet.2013.08.031_b0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/019262338501300402","article-title":"Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodules in a short-term assay and of hepatocellular carcinomas in a long-term assay","volume":"13","author":"Ogiso","year":"1985","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.canlet.2013.08.031_b0125","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/carcin\/12.8.1527","article-title":"Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols","volume":"12","author":"Wang","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2013.08.031_b0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbi.2009.07.015","article-title":"(-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R","volume":"182","author":"Yasuda","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2013.08.031_b0135","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research, design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.08.031_b0140","first-page":"879","article-title":"Expression of retinoid X receptor alpha is decreased in 3\u2032-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats","volume":"18","author":"Ando","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2013.08.031_b0145","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/carcin\/bgs303","article-title":"Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL\/KsJ-db\/db obese mice","volume":"33","author":"Terakura","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2013.08.031_b0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/carcin\/24.2.255","article-title":"Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen","volume":"24","author":"Kassie","year":"2003","journal-title":"Carcinogenesis"},{"issue":"2013","key":"10.1016\/j.canlet.2013.08.031_b0155","first-page":"179","article-title":"Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model","volume":"52","author":"Xiao","year":"2012","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.canlet.2013.08.031_b0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1349-7006.2009.01402.x","article-title":"Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL\/KsJ-db\/db mice","volume":"101","author":"Iwasa","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2013.08.031_b0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/156800911795538084","article-title":"Impact of renin-angiotensin system in hepatocellular carcinoma","volume":"11","author":"Yoshiji","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2013.08.031_b0170","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2012.05.019","article-title":"Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis","volume":"57","author":"Abdelmegeed","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2013.08.031_b0175","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/jn\/138.10.1866","article-title":"Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax","volume":"138","author":"Wang","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.canlet.2013.08.031_b0180","doi-asserted-by":"crossref","first-page":"E804","DOI":"10.1152\/ajpendo.00330.2002","article-title":"QUICKI is a useful index of insulin sensitivity in subjects with hypertension","volume":"284","author":"Chen","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2013.08.031_b0185","first-page":"80","article-title":"Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work","volume":"31","author":"Tsuda","year":"2003","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.canlet.2013.08.031_b0190","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbrc.2006.05.183","article-title":"Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis","volume":"346","author":"Nabeshima","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2013.08.031_b0195","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.21638","article-title":"Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis","volume":"45","author":"Hirose","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.08.031_b0200","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","volume":"40","author":"Yokohama","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.08.031_b0205","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/hep.510280512","article-title":"Fibrosis accelerates the development of enzyme-altered lesions in the rat liver","volume":"28","author":"Sakaida","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.08.031_b0210","doi-asserted-by":"crossref","first-page":"G642","DOI":"10.1152\/ajpgi.00037.2003","article-title":"Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver","volume":"285","author":"Bataller","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.canlet.2013.08.031_b0215","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.20665","article-title":"Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats","volume":"41","author":"Bataller","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.08.031_b0220","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.3748\/wjg.15.2579","article-title":"Renin-angiotensin system in the pathogenesis of liver fibrosis","volume":"15","author":"Pereira","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2013.08.031_b0225","first-page":"942","article-title":"Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats","volume":"51","author":"Moreno","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2013.08.031_b0230","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1365-2036.2010.04467.x","article-title":"Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis","volume":"32","author":"Rakoski","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2013.08.031_b0235","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"NASH CRN, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2013.08.031_b0240","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1158\/1055-9965.EPI-08-0528","article-title":"Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study","volume":"17","author":"Shimizu","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2013.08.031_b0245","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-05-1145","article-title":"Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study","volume":"66","author":"Bettuzzi","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2013.08.031_b0250","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.amjhyper.2007.08.006","article-title":"Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts","volume":"20","author":"Antonello","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.canlet.2013.08.031_b0255","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/jn\/138.9.1596","article-title":"Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src\/epidermal growth factor receptor\/Akt signaling pathway","volume":"138","author":"Papparella","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.canlet.2013.08.031_b0260","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1021\/jf904335g","article-title":"Antihypertensive effect of Benifuuki tea containing O-methylated EGCG","volume":"58","author":"Kurita","year":"2010","journal-title":"J. Agric. Food Chem."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351300606X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351300606X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:06:51Z","timestamp":1563754011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438351300606X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S030438351300606X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2013.08.031","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: Suppressing effects of EGCG on the development of liver lesions","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2013.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}